New Axon GenePix(R) microarray scanners and Arcturus(R) Laser Capture Microdissection instrument improve research speed and precision

SUNNYVALE, CA, May 14 – MDS Analytical

Technologies, a leader in innovative solutions for drug discovery and life

sciences research, announced today the release of three new molecular

biology instruments designed to advance genomics and microgenomics

discoveries for life sciences researchers. These instruments provide

scientists flexible and open platforms to perform sensitive and specific

molecular analysis in a number of fields, including stem cell research,

cancer research, proteomics, drug discovery and many others.

Two new microarray scanners, the Axon GenePix(R) 4300A and the Axon

GenePix(R) 4400A, represent the latest in a long line of industry-leading

microarray detection and analysis systems from MDS Analytical Technologies.

These newest platforms improve the efficiency of research experiments,

reduce the cost per data point, and offer the broadest applicability in the

microarray industry.

For researchers using laser capture microdissection (LCM), a method for

isolating cells under a microscope, the new, next-generation ArcturusXT(TM)

instrument uses the latest advances in microscope technology by employing

the Nikon Eclipse Ti-E inverted research microscope as its base. This new

technology improves speed, precision and flexibility during the

microdissection process – shortening the length of time required for

experiments and expanding application potential through an increased range

of available options.

“These new products continue our tradition of innovation and

excellence, offering reliability, flexibility, and high performance

solutions for life sciences researchers,” commented Dr. Andy Boorn,

president of MDS Analytical Technologies. “The Axon GenePix 4300A and 4400A

scanners provide customers with the ability to run the most advanced

microarray applications in the industry, which keeps them at the forefront

of this technology field. The new ArcturusXT system gives us a solid

platform upon which to offer increasingly beneficial features to

researchers who use our LCM technology.”

About MDS Analytical Technologies

MDS Analytical Technologies is a newly established MDS Inc. business

unit and is a world-class organization comprised of two main lines of

business. The Sciex product portfolio offers proven market leadership in

mass spectrometry through its joint ventures with two of the world’s

leading analytical instrumentation and life sciences companies, Applied

Biosystems, a business of the Applera Corporations and PerkinElmer Inc.

Molecular Devices’ product portfolio is the gold standard in

high-performance bioanalytical measurement systems that accelerate and

improve drug discovery and other life sciences research. Find out more at

http://www.moleculardevices.com or http://www.mdssciex.com.

About MDS Inc.

MDS Inc. (TSX: MDS; NYSE: MDZ) is a global life sciences company that

provides market-leading products and services that our customers need for

the development of drugs and diagnosis and treatment of disease. We are a

leading global provider of pharmaceutical contract research, medical

isotopes for molecular imaging, radiotherapeutics, and analytical

instruments. MDS, Inc. has more than 5,500 highly skilled people in 29

countries. Find out more at http://www.mdsinc.com or by calling 1-888-MDS-7222, 24

hours a day.